Nanil Therapeutics Inc.

1 known investors

Nanil Therapeutics develops AI-native discovery platforms for CNS-targeting therapeutic modalities, focusing on RNA-based approaches for neurodegenerative diseases like tauopathies and Alzheimer's. The company integrates quantum computing, generative AI, and molecular modeling to design and optimize mRNA therapeutics and identify blood-brain barrier-penetrant biologics.

AI & Machine LearningBiotechDeep Tech